Dr. Alexander Pantelyat, MD

Claim this profile

Johns Hopkins School of Medicine

Studies Cortical Basal Ganglionic Degeneration
Studies Upper Extremity Dysfunction
4 reported clinical trials
6 drugs studied

Affiliated Hospitals

Image of trial facility.
Johns Hopkins School Of Medicine

Clinical Trials Alexander Pantelyat, MD is currently running

Image of trial facility.

Music Therapy + Brain Stimulation

for Corticobasal Syndrome

This study is designed to investigate how musical patterns (e.g., patterned sensory enhancement, PSE) and non-invasive brain stimulation (e.g., transcranial direct current stimulation, tDCS) are effective to improve functional upper extremity performances in patients with corticobasal syndrome (CBS). 20 individuals with CBS will be randomly assigned to either PSE group (n= 10) or PSE+tDCS (n=10) group. Both interventions are 30 minutes long, twice a week for three weeks (a total of 6 sessions). Participants' self-reported and measurable outcomes including upper extremity function, kinematic quantities, quality of life, mood, cognitive level, and brain activity (e.g. electroencephalography, EEG) will be assessed in the baseline, pre- and post- each session, and follow-up phase. This study seeks to assess the possibility that music-based intervention and non-invasive brain stimulation may improve outcomes in CBS patients for patients' non-invasive but cost-effective rehabilitation settings in the future.
Recruiting1 award N/A3 criteria
Image of trial facility.

Virtual Music Therapy

for Alzheimer's Disease

This study is designed to assess the feasibility that individualized reminiscence-based virtual music therapy sessions can enhance autobiographical memory, mood, and cognition in patients with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's Disease (AD). 60 patients with MCI or mild dementia due to AD will receive two 30 minutes reminiscence-targeted virtual music therapy interventions per week for 8 weeks (a total of 16 sessions). Participants' (or supported by the study partner) self-reported and measurable outcomes including cognitive, anxiety, quality of life, and autobiographical memory will be assessed before and after the 8-week course of treatment. Blood-oxygenation level-dependent (BOLD) in functional magnetic resonance imaging (fMRI) will also be also measured before and after the 8-week course of treatment.
Recruiting1 award N/A2 criteria

More about Alexander Pantelyat, MD

Clinical Trial Related3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Alexander Pantelyat, MD has experience with
  • Patterned Sensory Enhancement (PSE)
  • Transcranial Direct Current Stimulation (tDCS)
  • Virtual Music Therapy
  • Scrambler Therapy
  • TENS Treatment
  • Rhythmic Auditory Stimulation (RAS)

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Alexander Pantelyat, MD specialize in?
Is Alexander Pantelyat, MD currently recruiting for clinical trials?
Are there any treatments that Alexander Pantelyat, MD has studied deeply?
What is the best way to schedule an appointment with Alexander Pantelyat, MD?
What is the office address of Alexander Pantelyat, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security